INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 1 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $21,000 | -8.7% | 41,240 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | -20.7% | 41,240 | +49.9% | 0.00% | – |
| Q3 2019 | $29,000 | -87.1% | 27,519 | -85.8% | 0.00% | – |
| Q2 2019 | $224,000 | -47.2% | 193,464 | -11.9% | 0.00% | – |
| Q1 2019 | $424,000 | -11.5% | 219,610 | +6.0% | 0.00% | – |
| Q4 2018 | $479,000 | -66.1% | 207,194 | +0.1% | 0.00% | – |
| Q3 2018 | $1,414,000 | +166.8% | 206,979 | +820.0% | 0.00% | – |
| Q2 2018 | $530,000 | – | 22,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|